Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy

A 73-year-old man developed diplopia after the administration of pembrolizumab for lung adenocarcinoma. He had ptosis and external ophthalmoplegia without general muscle weakness. Serum CK levels were elevated. Although autoantibodies to acetylcholine receptor and muscle-specific kinase, the edropho...

Descripción completa

Detalles Bibliográficos
Autores principales: Onda, Asako, Miyagawa, Shinji, Takahashi, Naoko, Gochi, Mina, Takagi, Masamichi, Nishino, Ichizo, Suzuki, Shigeaki, Oishi, Chizuko, Yaguchi, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599941/
https://www.ncbi.nlm.nih.gov/pubmed/30713313
http://dx.doi.org/10.2169/internalmedicine.1956-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599941/
https://www.ncbi.nlm.nih.gov/pubmed/30713313
http://dx.doi.org/10.2169/internalmedicine.1956-18

Ejemplares similares